People with AIDS (PWA) Since Highly Active Antiretroviral Therapy, 1996

Dunbar, Deanne
June 2011
Journal of Medical Humanities;Jun2011, Vol. 32 Issue 2, p115
Academic Journal
lthough clarity about HIV transmission biology and effective therapy should mean that an AIDS diagnosis is more socially acceptable today, for some groups the cultural stigma of HIV infection has changed little in the last 30 years. This paper will examine why representations of HIV-positive gay men suggest they pose a special civic risk and how these conceptualizations have harnessed cultural anxieties about racial and sexual minorities to shape public policy and behavior since the advent of Highly Active Antiretroviral Therapy (HAART) in 1996.


Related Articles

  • Antiretroviral Therapy as HIV Prevention: Status and Prospects. Mayer, Kenneth H.; Venkatesh, Kartik K. // American Journal of Public Health;Oct2010, Vol. 100 Issue 10, p1867 

    As antiretroviral treatment of HIV infection has become increasingly accessible, attention has focused on whether these drugs can used for prevention because of increased tolerability of newer medications, decreased cost, and the limitations of other approaches. We review the status of...

  • HIV treatment prevents transmission of HIV.  // Africa Health;May2011, Vol. 33 Issue 4, p11 

    The article discusses the report from the US National Institutes of Health which found that an effective antiretroviral therapy regimen for HIV-positive person could prevent the risk of transmitting the virus to their uninfected sexual partner.

  • INFANT BREASTFEEDING AND HIV: A REVIEW ARTICLE. Nandini, D. B.; Deepak, B. S. // Annals & Essences of Dentistry;Apr-Jun2010, Vol. 2 Issue 2, p82 

    Human Immunodeficiency Virus (HIV) and infant feeding is a complex issue, and there are still significant knowledge gaps, including whether antiretroviral prophylaxis for an Infant during breastfeeding, or antiretroviral treatment for breastfeeding mother, are safe and effective in reducing HIV...

  • Antiretroviral medication for preventing HIV infection in nonoccupational settings. Bogoch, Isaac I.; Scully, Eileen P.; Zachary, Kimon C. // CMAJ: Canadian Medical Association Journal;7/10/2012, Vol. 184 Issue 10, p1153 

    The article presents a review of the evidence and clinical practice for pharmacologic strategies employed to prevent HIV transmission among people exposed to the virus in nonoccupational settings. It states that the strategies include postexposure prophylaxis, preexposure prophylaxis and...

  • Transmission of HIV-1 Drug-Resistant Variants: Prevalence and Effect on Treatment Outcome. Jakobsen, Martin R.; Tolstrup, Martin; Søgaard, Ole S.; Jørgensen, Louise B.; Gorry, Paul R.; Laursen, Alex; Østergaard, Lars // Clinical Infectious Diseases;2/15/2010, Vol. 50 Issue 4, p566 

    Background. Human immunodeficiency virus type 1 (HIV-1) drug resistance is an important threat to the overall success of antiretroviral therapy (ART). Because of the limited sensitivity of commercial assays, transmitted drug resistance (TDR) may be underestimated; thus, the effect that TDR has...

  • Antiretroviral therapy interruptions: impact on HIV treatment and transmission. Dubrocq, Gueorgui; Rakhmanina, Natella // HIV/AIDS - Research & Palliative Care;Jun2018, Vol. 10, p91 

    No abstract available.

  • Factors associated with access to HIV care and treatment in a prevention of mother to child transmission programme in urban Zimbabwe. Muchedzi, Auxilia; Chandisarewa, Winfreda; Keatinge, Jo; Stranix-Chibanda, Lynda; Woelk, Godfrey; Mbizvo, Elizabeth; Shetty, Avinash K. // Journal of the International AIDS Society;2010, Vol. 13 Issue 1, p1 

    Background: This cross-sectional study assessed factors affecting access to antiretroviral therapy (ART) among HIVpositive women from the prevention of mother to child transmission HIV programme in Chitungwiza, Zimbabwe. Methods: Data were collected between June and August 2008. HIV-positive...

  • Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting. Montaner, Julio S.G.; Lima, Viviane D.; Harrigan, P. Richard; Lourenço, Lillian; Yip, Benita; Nosyk, Bohdan; Wood, Evan; Kerr, Thomas; Shannon, Kate; Moore, David; Hogg, Robert S.; Barrios, Rolando; Gilbert, Mark; Krajden, Mel; Gustafson, Reka; Daly, Patricia; Kendall, Perry // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    Background: There has been renewed call for the global expansion of highly active antiretroviral therapy (HAART) under the framework of HIV treatment as prevention (TasP). However, population-level sustainability of this strategy has not been characterized. Methods: We used population-level...

  • Postnatal HIV-1 Transmission after Cessation of Infant Extended Antiretroviral Prophylaxis and Effect of Maternal Highly Active Antiretroviral Therapy. Taha, Taha E.; Kumwenda, Johnstone; Cole, Stephen R.; Hoover, Donald R.; Kafulafula, George; Fowler, Mary Glenn; Thigpen, Michael C.; Qing Li; Kumwenda, Newton I.; Mofenson, Lynne // Journal of Infectious Diseases;11/15/2009, Vol. 200 Issue 10, p1490 

    Background. The association between postnatal human immunodeficiency virus type 1 (HIV-1) transmission and maternal highly active antiretroviral therapy (HAART) after infant extended antiretroviral prophylaxis was assessed. Methods. A follow-up study was conducted for the Post-Exposure...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics